HealthQuill COVID-19 Variant
The European Medicines Agency has allowed marketing authorisation for the Covid-19 variant vaccine made by Pfizer and BioNTech SE for children aged six months and older, according to a joint statement.
Drugs Health Pharma

Pfizer, BioNTech gets EMA marketing nod for variant Covid-19 vaccine

The European Medicines Agency has allowed marketing authorisation for the Covid-19 variant vaccine made by Pfizer and BioNTech SE for children aged six.

Read More
Britain’s Medicines and Healthcare products Regulatory Agency has cleared a vaccine made by Pfizer Inc., and its German partner BioNTech SE that targets Omicron XBB.1.5 subvariant alone.
Drugs Health Pharma

Pfizer, BioNTech’s Covid-19 variant vaccine gets UK nod

HQ Team September 6, 2023: Britain’s Medicines and Healthcare products Regulatory Agency has cleared a vaccine made by Pfizer Inc., and its German.

Read More
The WHO has updated the EG.5 variability of the COVID-19 virus to a ‘variant of interest’ — with genetic changes that are predicted or known to affect virus characteristics, such as transmissibility, virulence, antibody evasion, susceptibility to therapeutics and detectability.
Drugs Health Pharma

WHO labels Covid-19 variant EG.5 as ‘variant of interest’; cases rise

HQ Team August 10, 2023: The WHO has updated the EG.5 variability of the COVID-19 virus to a ‘variant of interest’ — with.

Read More
A new mutant of the COVID-19 virus is spreading across the UK rapidly, and the number of people infected with the disease is rising, government data shows.
Drugs Health Pharma

New COVID-19 virus variant cases rising rapidly in England: UK Health 

HQ Team August 5, 2023: A new mutant of the COVID-19 virus is spreading across the UK rapidly, and the number of people.

Read More
X